Edesa Biotech, Inc.

EDSA - CIK 0001540159

Market cap-

Rank-

SEC filings713

EDSA income statement (quarterly)

The table below shows Edesa Biotech, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.

Line item	Q1 2026	Q4 2025	Q2 2025	Q1 2025	Q4 2024	Q2 2024
Revenue	-	-	-	-	-	-
Cost of revenue	-	-	-	-	-	-
Gross profit	-	-	-	-	-	-
R&D	$2.77M	$1.12M	$939.07K	$484.31K	$1.02M	$897.30K
SG&A

EDSA annual revenue (10-K history)

Edesa Biotech, Inc. reported annual revenue of $0.00 for fiscal year 2021. That is down 100.0% from $328.80K in fiscal 2020. Over the 9 fiscal years shown, annual revenue declined from $286.05K (FY 2012) to $0.00. Figures come from the company's audited annual reports as filed with the SEC.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.